VI2OLET iodine
Commercial- Indications
- Fibrocystic breast condition
Company intelligence / Profile preview
BioPharmX
San Jose, California, United Statessec.gov ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
BioPharmX was a specialty pharmaceutical company focused on developing innovative prescription products using its proprietary HyantX™ drug delivery system to address chronic dermatologic conditions such as acne and rosacea that are underserved by current therapies. In January 2020, BioPharmX announced a definitive agreement to merge with Timber Pharmaceuticals—a move that expanded its pipeline into rare dermatological diseases including congenital ichthyosis and tuberous sclerosis complex-related facial angiofibromas. The combined entity’s lead programs include several late-stage clinical assets targeting orphan skin diseases.
- Therapeutic areas
- Rare DiseasesDermatologyRheumatology
- Modalities
- Topical drug deliverySmall molecules (e.g., isotretinoin, rapamycin)Proprietary drug delivery systems (HyantX™)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships disclosed prior to or during the time of available data.
Beyond the preview
Go deeper on BioPharmX.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioPharmX.